Lexicon Pharmaceuticals, Inc. Insider Trading

LXRX

⊜ Compare

Last 12 months

Insiders bought 723K on the open market and sold nothing.

Net open-market

+723K

4 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Feb 2026

Feb 25, 2026

Get an email when LXRX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 25	Raymond Debbane Director	Bought	2,000	$1.49	3K	<0.1%	Form 4
Feb 23	Raymond Debbane Director	Bought	100,000	$1.47	147K	0.2%	Form 4
Feb 19 – 20	Raymond Debbane Director	Bought 2 parts	150,000	$1.47 average	220K	0.3%	Form 4
Feb 13 – 18	Raymond Debbane Director	Bought 3 parts	268,497	$1.31 average	353K	0.5%	Form 4
Feb 2	Artal Group S.a. Large holder	Bought	1,538,462	$1.30	$2M	419%	Form 4

Feb 25
Raymond Debbane
Director · bought 2,000 at $1.49
3K
<0.1% of stake
Feb 23
Raymond Debbane
Director · bought 100,000 at $1.47
147K
0.2% of stake
Feb 19 – 20
Raymond Debbane
Director · bought 150,000 at avg $1.47
220K
0.3% of stake
Feb 13 – 18
Raymond Debbane
Director · bought 268,497 at avg $1.31
353K
0.5% of stake
Feb 2
Artal Group S.a.
Large holder · bought 1,538,462 at $1.30
$2M
419% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LXRX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LXRX

CompareIntrinsic value

NERVMinerva Neurosciences Inc.

$2.57+9.36%10

CRNXCrinetics Pharmaceuticals Inc.

No recent price40

CELUCelularity Inc.

$0.81-1.00%0

WVEWave Life Sciences Ltd.

$3.62+1.12%40

BFRIBiofrontera Inc.

$0.90+1.55%30

CUECue Biopharma, Inc.

$19.84-4.89%40

ZYMEZymeworks Inc.

$30.98+2.82%10

VTVTvTv Therapeutics Inc.

$24.03+2.04%40

Held by ETFs

LXRX is in 11 US ETFs. The largest of them, with LXRX's weight in each:

Spot a number that looks wrong? Check it in LXRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LXRX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.